Litigation Details for Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)
✉ Email this page to a colleague
Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-02-12 |
Court | District Court, S.D. California | Date Terminated | 2022-06-09 |
Cause | 35:0271 Patent Infringement | Assigned To | Cathy Ann Bencivengo |
Jury Demand | Plaintiff | Referred To | Mitchell D. Dembin |
Patents | 10,006,091; 10,086,011; 10,183,012; 10,323,013; 7,022,125; 8,008,003; 8,013,002; 8,063,015; 9,081,016; 9,200,002 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Nuvasive, Inc. v. Alphatec Holdings, Inc.
Biologic Drugs cited in Nuvasive, Inc. v. Alphatec Holdings, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-11-15 | 355 | Pretrial Order | 88:6-88:13 89:11-13 5 89:20-90:10 6 91:17-92:16 93:8-9 7 93:17-95:8 …time for the 20 ’832 Patent, ’801 Patent, and ’531 Patent. 21 13. Alphatec…jointly Alphatec) infringe three U.S. Patents. 8 U.S. Patent No. 8,439,832 9 (which…generally be referred to as the ‘832 Patent); 10 U.S. Patent No. 7,819,801 11 (which…generally be referred to as the ‘801 Patent); and 12 U.S. Patent No. 9,974,531 13 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |